1
|
Maillet F, Nguyen Y, Espitia O, Perard L, Salvarani C, Rivière E, Ndiaye D, Durel CA, Guilpain P, Mouthon L, Kernder A, Loricera J, Cohen P, Melki I, de Moreuil C, Limal N, Mékinian A, Costedoat-Chalumeau N, Morel N, Boutemy J, Raffray L, Allain JS, Devauchelle V, Kone-Paut I, Fabre M, Durel M, Dossier A, Abad S, Visentini M, Bigot A, Yildiz H, Fain O, Samson M, Gondran G, Abitbol V, Terrier B. Association between large vessel vasculitis and inflammatory bowel disease: a case-control study. Rheumatology (Oxford) 2025; 64:3724-3732. [PMID: 39898825 DOI: 10.1093/rheumatology/keaf030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2024] [Revised: 12/08/2024] [Accepted: 12/27/2024] [Indexed: 02/04/2025] Open
Abstract
OBJECTIVES To describe the characteristics and outcome of patients with the association of large vessel vasculitis (LVV, Takayasu arteritis [TA] or GCA) and IBD. METHODS An observational, multicentre, retrospective case-control study. Cases were LVV-IBD patients from European countries, whereas controls had isolated LVV (iLVV). RESULTS A total of 39 TA-IBD and 12 GCA-IBD cases were enrolled, compared with 52 isolated GCA (iGCA) and 93 isolated TA (iTA) controls. LVV occurred after IBD in 56% in TA-IBD and 75% in GCA-IBD, with a median interval of 1 year (interquartile range [IQR] 1-7) in TA-IBD and 8.6 years (IQR 1-17.7) in GCA-IBD. Crohn's disease was more common in TA-IBD (67%), whereas ulcerative colitis was more common in GCA-IBD (58%). Compared with iTA, TA-IBD were significantly younger at diagnosis of TA (median age 27 vs 37 years, P < 0.001) and had more upper limb claudication (36% vs 12%, P = 0.006). GCA-IBD patients had more frequent arterial thickening or stenosis than controls (75% vs 30%, respectively, P = 0.044) and tended to more frequently involve gastrointestinal arteries (20% vs 0%, respectively, P = 0.06). LVV occurred in IBD patients despite treatment with glucocorticoids (36%), azathioprine (25%) or TNF-alpha blockers (29%). The presence of the IBD was not associated with a higher LVV relapse rate in multivariate analysis (adjusted hazard ratio [aHR] 0.62 [0.13-2.83] for GCA and aHR 0.92 [0.44-1.89] for TA). CONCLUSION This study identifies specific clinical and imaging characteristics of LVV-IBD patients, in particular a more severe vascular presentation of GCA-IBD patients compared with iGCA patients.
Collapse
Affiliation(s)
- François Maillet
- Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France
| | - Yann Nguyen
- Department of Internal Medicine, Beaujon University Hospital, AP-HP.Nord, Université Paris Cité, Clichy, France
- Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université de Paris Cité, Paris, France
| | - Olivier Espitia
- Nantes Université, CHU Nantes, Department of Internal and Vascular Medicine, Institut du thorax, INSERM UMR1087/CNRS UMR 6291, Team III Vascular & Pulmonary diseases, Nantes, France
| | - Laurent Perard
- Department of Internal Medicine, Saint Joseph Saint Luc Hospital, Lyon, France
| | - Carlo Salvarani
- Division of Rheumatology, Azienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy
| | - Etienne Rivière
- Department of Internal Medicine, Haut-Lévèque University Hospital, Bordeaux, France
| | - Dieynaba Ndiaye
- Department of Internal Medicine, Haut-Lévèque University Hospital, Bordeaux, France
| | - Cécile-Audrey Durel
- Department of Internal Medicine, Saint Joseph Saint Luc Hospital, Lyon, France
| | - Philippe Guilpain
- Department of Internal Medicine, Saint-Eloi University Hospital, Montpellier, France
| | - Luc Mouthon
- Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France
| | - Anna Kernder
- Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany
| | - Javier Loricera
- Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain
| | - Pascal Cohen
- Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France
| | - Isabelle Melki
- Department of Infectious Disease and Internal Medicine, Reference Center for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Robert Debré University Hospital, AP-HP, Paris, France
| | - Claire de Moreuil
- Department of Internal Medicine, Brest University Hospital, Brest, France
| | - Nicolas Limal
- Department of Internal Medicine, Henri Mondor University Hospital, AP-HP, Créteil, France
| | - Arsène Mékinian
- Department of Internal Medicine, Saint-Antoine University Hospital, AP-HP, Paris, France
| | - Nathalie Costedoat-Chalumeau
- Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France
| | - Nathalie Morel
- Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France
| | - Jonathan Boutemy
- Department of Internal Medicine, Caen University Hospital, Caen, France
| | - Loïc Raffray
- Department of Internal Medicine, Saint-Denis University Hospital, Reunion, France
| | | | | | - Isabelle Kone-Paut
- Department of Paediatric Rheumatology and CEREMAIA, ERN RITA member, Bicêtre University Hospital, AP-HP, Paris, France
| | - Marc Fabre
- Department of Internal Medicine, Pierre Oudot Hospital, Bourgoin-Jallieu, France
| | - Marie Durel
- Department of Internal Medicine, Robert Schuman Hospital, Vantoux, France
| | - Antoine Dossier
- Department of Internal Medicine, Bichat University Hospital, AP-HP, Paris, France
| | - Sébastien Abad
- Department of Internal Medicine, Avicenne University Hospital, AP-HP, Bobigny, France
| | - Marcella Visentini
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
| | - Adrien Bigot
- Department of Internal Medicine, Tours University Hospital, Tours, France
| | - Halil Yildiz
- Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | - Olivier Fain
- Department of Internal Medicine, Saint-Antoine University Hospital, AP-HP, Paris, France
| | - Maxime Samson
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France
| | - Guillaume Gondran
- Department of Internal Medicine, Limoges University Hospital, Limoges, France
| | - Vered Abitbol
- Department of Gastroenterology, Cochin University Hospital, AP-HP, Paris, France
| | - Benjamin Terrier
- Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France
| |
Collapse
|
2
|
Tian X, Zeng X. Chinese guideline for the diagnosis and treatment of Takayasu's arteritis (2023). RHEUMATOLOGY AND IMMUNOLOGY RESEARCH 2024; 5:5-26. [PMID: 38571931 PMCID: PMC10985707 DOI: 10.1515/rir-2024-0002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/29/2024] [Accepted: 02/19/2024] [Indexed: 04/05/2024]
Abstract
Takayasu's arteritis (TAK) is a chronic granulomatous inflammatory disease that involves aorta and its primary branches. It is characterized by wall thickening, stenosis/obliteration or aneurysm formation of the involved arteries. In order to standardize the diagnosis and treatment of TAK in China, a clinical practice guideline with an evidence-based approach is developed under the leadership of National Clinical Medical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID). Eleven recommendations for 11 clinical questions that are important to the diagnosis and treatment of TAK are developed based on the latest evidence and expert opinions combined with real clinical practice in China.
Collapse
Affiliation(s)
- Xinping Tian
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science& Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China
| | - Xiaofeng Zeng
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science& Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China
| |
Collapse
|